These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19039694)

  • 1. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Matson JL; Fodstad JC; Rivet TT
    J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations.
    Kalachnik JE; Sprague RL
    J Clin Psychol; 1993 Mar; 49(2):177-89. PubMed ID: 8098048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Sprague RL; Kalachnik JE; Slaw KM
    Ment Retard; 1989 Jun; 27(3):141-8. PubMed ID: 2739567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?
    Mahan S; Holloway J; Bamburg JW; Hess JA; Fodstad JC; Matson JL
    Res Dev Disabil; 2010; 31(6):1561-9. PubMed ID: 20542660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations.
    Sprague RL; Kalachnik JE
    Psychopharmacol Bull; 1991; 27(1):51-8. PubMed ID: 1862206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akathisia in adults with severe and profound intellectual disability: a psychometric study of the MEDS and ARMS.
    Garcia MJ; Matson JL
    J Intellect Dev Disabil; 2008 Jun; 33(2):171-6. PubMed ID: 18569404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug side effects for persons with intellectual disability.
    Matson JL; Mahan S
    Res Dev Disabil; 2010; 31(6):1570-6. PubMed ID: 20580203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales.
    de Kuijper GM; Hoekstra PJ
    J Clin Psychopharmacol; 2016 Oct; 36(5):508-12. PubMed ID: 27529770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the Matson Evaluation of Drug Side Effects (MEDS).
    Matson JL; Cervantes PE
    Res Dev Disabil; 2013 May; 34(5):1849-53. PubMed ID: 23528442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of lip dyskinesia associated with neuroleptic withdrawal.
    Newell KM; Bodfish JW; Mahorney SL; Sprague RL
    Am J Ment Retard; 2000 Jul; 105(4):260-8. PubMed ID: 10934568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic dyskinesia examination of profoundly mentally retarded persons: cooperation and assessment.
    Granger DA; Yurkunski JM; Miller NH; Swanson JM; Crinella FC
    Am J Ment Defic; 1987 Sep; 92(2):155-60. PubMed ID: 2893551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of tardive dyskinesia as measured on the Dyskinesia Identification System--Coldwater.
    Bostrom AC; Walker MK
    Nurs Res; 1990; 39(5):274-9. PubMed ID: 2399131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of nonassessable items and Cooperation level of the retarded during systematic dyskinesia examinations.
    Kalachnik JE; Kidd-Nielsen P; Harder SR
    Psychopharmacol Bull; 1983; 19(1):16-9. PubMed ID: 6828620
    [No Abstract]   [Full Text] [Related]  

  • 16. Reliability of the Matson Evaluation of Drug Side Effects Scale (MEDS).
    Matson JL; Mayville EA; Bielecki J; Barnes WH; Bamburg JW; Baglio CS
    Res Dev Disabil; 1998; 19(6):501-6. PubMed ID: 9836321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between kinematic and rating scale measures of tardive dyskinesia in a developmentally disabled population.
    Sprague RL; Korach MS; van Emmerik RE; Newell KM
    J Nerv Ment Dis; 1993 Jan; 181(1):42-7. PubMed ID: 8093476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled.
    Sprague RL; Kalachnik JE; Breuning SE; Davis VJ; Ullmann RK; Cullari S; Davidson NA; Ferguson DG; Hoffner BA
    Psychopharmacol Bull; 1984; 20(2):328-38. PubMed ID: 6728999
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of postural sway patterns in tardive dyskinesia.
    van Emmerik RE; Sprague RL; Newell KM
    Mov Disord; 1993 Jul; 8(3):305-14. PubMed ID: 8101968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity.
    Gerlach J; Korsgaard S; Clemmesen P; Lauersen AM; Magelund G; Noring U; Povlsen UJ; Bech P; Casey DE
    Acta Psychiatr Scand; 1993 Apr; 87(4):244-52. PubMed ID: 8098178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.